Protagonist Therapeutics PTGX
$121.40 −$2.62 (-2.11%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $121.40 0.00%
Open$123.41
Prev close$124.02
Day range$120.15 – $125.91
Volume600.7K
Market cap$7.92B
P/E (TTM)25.7
Dividend yield–
Earnings
Average move on report day±19.7%last 5 reports
Closed higher2 of 540% of the time
Best reaction+83.7%
Worst reaction-6.2%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2020/Q4 | 10 Mar 2021 | After Market | ±15.8% | +4.09% | Within range |
| 2020/Q1 | 7 May 2020 | None | – | +83.70% | – |
| 2019/Q4 | 10 Mar 2020 | After Market | – | -6.16% | – |
| 2018/Q4 | 12 Mar 2019 | After Market | – | -1.46% | – |
| 2017/Q4 | 7 Mar 2018 | After Market | – | -3.16% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$274.41M+5,723.6% YoY
Operating profit$218.33M+570.3% YoY
Net profit$220.02M+659.3% YoY
Diluted EPS$3.07+595.2% YoY
Free cash flow-$23.46M-1,058.4% YoY
Operating cash flow-$23.22M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin99.6%
Operating margin58.6%
Net margin62.0%
Return on equity39.6%
Return on assets37.0%
Return on invested capital36.1%
Current ratio19.85
Liabilities / assets5.4%
Cash & investments$800.06M
Total debt$6.18M
Net cash (debt)$793.89M
Free cash flow / sales19.8%
No comments yet — be the first to weigh in on PTGX.
Sign in to join the discussion.